Thoracic Research and Practice
ORIGINAL INVESTIGATIONS

Compliance, Side Effects and Results of CPAP Therapy in Cases with Obstructive Sleep Apnea Syndrome

1.

Department of Chest Diseases, Dokuz Eylül University School of Medicine, Izmir, Turkey

2.

Department of Neurology, Dokuz Eylül University School of Medicine, Izmir, Turkey

3.

Department of Pulmonology, Dokuz Eylül University Hospital, İnciralti, İzmir, Turkey

4.

Department of Chest Diseases, Dokuz Eylül University School of Medicine, İzmir, Turkey

5.

Department of Otolaryngorhinology, Dokuz Eylül University School of Medicine, Izmir, Turkey

6.

Department of Chest Diseases, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey

7.

Department of Chest Diseases, Dokuz Eylül University School of Medicine, İzmir, Turkey

Thorac Res Pract 2005; 6: Turkish Respiratory Journal 135-138
Read: 470 Downloads: 309 Published: 12 October 2021

Continuous positive airway pressure (CPAP) therapy in obstructi­ve sleep apnea syndrome (OSAS) is an efficient method. Epworth Sleepiness Scale and a standard questionnaire were applied to 23 cases (mean age: 57.6±10.7 years; 17 (73.9%) male, 6 (26.1%) fe­male) diagnosed as OSAS with full polysomnography who were prescribed to use CPAP between May 1999 and January 2001. Mean body mass index (BMI) was 3O.7±5.9 kg/m2 in males and 34.4+8.9 kg/m2 in females, mean apne-hypopnea index (AHI) was 48.9±24-1 and mean duration of CPAP therapy was 234.2±212.6 days (18-810). Fourteen (60.8%) patients were using CPAP for > 6 hours a night in seven days a week. The most common side effect was hyperaemia and erosion of the nose. Dryness of the eyes and up­per airways, awaking at night and noise associated with CPAP we­re more rare complaints. Mean score of Epworth Sleepiness Scale before CPAP therapy was 15.1 ±5.1 and after therapy it was 5.5±4.6. The difference was statistically significant (p=0.000). No statistical significant correlation was detected between the score after CPAP usage and the duration of CPAP therapy (p=0.274). Symptoms li­ke snoring daytime sleepiness and witnessed apnea were found to be significantly decreased. In conclusion, although side effects predo­minantly associated with nasal masks limit usage in patients using CPAP, subjective improvement in symptoms is a factor increasing patient compliance.

Files
EISSN 2979-9139